{"nct_id":"NCT04442737","title":"A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain","status":"COMPLETED","status_verified_date":"2025-03","start_date":"2020-07-01","start_date_type":"ACTUAL","primary_completion_date":"2023-08-07","primary_completion_date_type":"ACTUAL","completion_date":"2023-08-30","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["JNJ"]}